巧特欣与欣母沛预防剖宫产产后出血的效果比较

Comparison of the effect of Duratocin and Hemabate in preventing postpartum hemorrhage of caesarean section

目的:观察巧特欣与欣母沛预防剖宫产产后出血的效果。方法:2018年8月-2019年8月收治剖宫产患者84例,按用药不同分为两组,各42例。对照组给予欣母沛预防产后出血;试验组则给予巧特欣。比较两组产后情况。结果:试验组产后2 h、2~24 h出血量及产后不良反应发生率均低于对照组,差异有统计学意义(P<0.05)。试验组产后子宫张力维持在“硬”状态时间及产后12 h相关凝血指标水平均优于对照组,差异有统计学意义(P<0.05)。结论:剖宫产患者应用巧特欣治疗效果明显优于欣母沛,且安全性较高。

Objective:To observe the effect of Duratocin and Hemabate in preventing postpartum hemorrhage of cesarean section.Methods:From August 2018 to August 2019,84 cesarean section patients were selected and they were divided into the two groups according to different drugs with 42 patients in each group.The control group was given Hemabate to prevent postpartum hemorrhage.The experimental group was given Duratocin.The postpartum conditions between the two groups were compared.Results:The blood loss volume and the incidence of postpartum adverse reactions in 2 h,2~24 h of postpartum in the experimental group were all lower than the control group,with the differences were statistically significant(P<0.05).The postpartum uterine tension in the experimental group was maintained at a"hard"state time and the level of related coagulation indicators at 12 h of postpartum were better than the control group,with the differences were statistically significant(P<0.05).Conclusion:The therapeutic effect of the Duratocin in the treatment of patients with cesarean section is obviously better than Hemabate,and the safety is higher.